Hecht FM - Search Results

1

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Kassanjee R, Pilcher CD, Busch MP, Murphy G, Facente SN, Keating SM, Mckinney E, Marson K, Price MA, Martin JN, Little SJ, Hecht FM, Kallas EG, Welte A; Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA). Kassanjee R, et al. Among authors: hecht fm. AIDS. 2016 Sep 24;30(15):2361-71. doi: 10.1097/QAD.0000000000001209. AIDS. 2016. PMID: 27454561 Free PMC article.

2

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP. Janssen RS, et al. Among authors: hecht fm. JAMA. 1998 Jul 1;280(1):42-8. doi: 10.1001/jama.280.1.42. JAMA. 1998. PMID: 9660362

3

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A. Bangsberg DR, et al. Among authors: hecht fm. AIDS. 2000 Mar 10;14(4):357-66. doi: 10.1097/00002030-200003100-00008. AIDS. 2000. PMID: 10770537

4

Adherence: a necessity for successful HIV combination therapy.

Chesney MA, Ickovics J, Hecht FM, Sikipa G, Rabkin J. Chesney MA, et al. Among authors: hecht fm. AIDS. 1999;13 Suppl A:S271-8. AIDS. 1999. PMID: 10885784 Review.

5

Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection.

Stranford SA, Ong JC, Martinez-Marino B, Busch M, Hecht FM, Kahn J, Levy JA. Stranford SA, et al. Among authors: hecht fm. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):597-602. doi: 10.1073/pnas.98.2.597. Epub 2001 Jan 2. Proc Natl Acad Sci U S A. 2001. PMID: 11136234 Free PMC article.

6

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Hecht FM, et al. AIDS. 2002 May 24;16(8):1119-29. doi: 10.1097/00002030-200205240-00005. AIDS. 2002. PMID: 12004270 Clinical Trial.

7

Time trends in primary HIV-1 drug resistance among recently infected persons.

Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO. Grant RM, et al. Among authors: hecht fm. JAMA. 2002 Jul 10;288(2):181-8. doi: 10.1001/jama.288.2.181. JAMA. 2002. PMID: 12095382

8

Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy.

Jacobson MA, Liu L, Khayam-Bashi H, Deeks SG, Hecht FM, Kahn J. Jacobson MA, et al. Among authors: hecht fm. AIDS. 2003 Apr 11;17(6):917-9. doi: 10.1097/00002030-200304110-00019. AIDS. 2003. PMID: 12660541 No abstract available.

9

Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP. Rawal BD, et al. Among authors: hecht fm. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):349-55. doi: 10.1097/00126334-200307010-00009. J Acquir Immune Defic Syndr. 2003. PMID: 12843746

10

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM. Deeks SG, et al. Among authors: hecht fm. Blood. 2004 Aug 15;104(4):942-7. doi: 10.1182/blood-2003-09-3333. Epub 2004 Apr 29. Blood. 2004. PMID: 15117761 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

610 results

Search Page